Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Baxter International Inc (BAX)

Baxter International Inc (BAX)
27.35 x 1 28.13 x 3
Post-market by (Cboe BZX)
28.14 -2.61 (-8.49%) 04/10/25 [NYSE]
27.35 x 1 28.13 x 3
Post-market 27.79 -0.35 (-1.24%) 17:23 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
27.62
Day High
30.25
Open 30.09
Previous Close 30.75 30.75
Volume 6,546,771 6,546,771
Avg Vol 4,929,523 4,929,523
Stochastic %K 29.60% 29.60%
Weighted Alpha -32.37 -32.37
5-Day Change -3.21 (-10.24%) -3.21 (-10.24%)
52-Week Range 26.25 - 42.47 26.25 - 42.47
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,772,414
  • Shares Outstanding, K 512,924
  • Annual Sales, $ 10,636 M
  • Annual Income, $ -649,000 K
  • EBIT $ 439 M
  • EBITDA $ 1,911 M
  • 60-Month Beta 0.64
  • Price/Sales 1.35
  • Price/Cash Flow 5.88
  • Price/Book 2.03

Options Overview Details

View History
  • Implied Volatility 59.42% ( +16.02%)
  • Historical Volatility 53.04%
  • IV Percentile 99%
  • IV Rank 90.69%
  • IV High 63.60% on 04/08/25
  • IV Low 18.67% on 06/24/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 10,662
  • Volume Avg (30-Day) 3,988
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 89,110
  • Open Int (30-Day) 70,719

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.48
  • Number of Estimates 6
  • High Estimate 0.49
  • Low Estimate 0.48
  • Prior Year 0.65
  • Growth Rate Est. (year over year) -26.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.25 +7.20%
on 04/09/25
Period Open: 36.56
36.57 -23.05%
on 03/11/25
-8.42 (-23.03%)
since 03/10/25
3-Month
26.25 +7.20%
on 04/09/25
Period Open: 29.42
37.74 -25.44%
on 03/10/25
-1.28 (-4.35%)
since 01/10/25
52-Week
26.25 +7.20%
on 04/09/25
Period Open: 42.00
42.47 -33.75%
on 04/11/24
-13.86 (-33.00%)
since 04/10/24

Most Recent Stories

More News
Wall Street's euphoria sends US stocks to historic gains after Trump pauses most of his tariffs

U.S. stocks soared to one of their best days in history on a euphoric Wall Street after President Donald Trump said he would back off on most of his tariffs temporarily

$SPX : 5,268.05 (-3.46%)
JNJ : 148.69 (-1.51%)
BAX : 28.14 (-8.49%)
$DOWI : 39,593.66 (-2.50%)
$IUXX : 18,343.57 (-4.19%)
PFE : 21.59 (-4.00%)
DAL : 39.36 (-11.09%)
BMY : 50.46 (-6.10%)
Is Baxter International Stock Underperforming the S&P 500?

Despite its underperformance over the past year, Baxter International has notably outpaced the S&P 500 in the recent months and analysts remain cautiously optimistic about the stock’s prospects.

$SPX : 5,268.05 (-3.46%)
BAX : 28.14 (-8.49%)
ALGN : 160.14 (-2.96%)
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector?

Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.

XLV : 134.89 (-2.79%)
BDX : 199.12 (-4.89%)
BAX : 28.14 (-8.49%)
Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings?

Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings?

TTD : 49.27 (-8.96%)
BAX : 28.14 (-8.49%)
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq

Baxter International Inc. BAX recently introduced Voalte Linq , a lightweight, wearable badge powered by Scotty assistant, a voice-activated technology, at the 2025 HIMSS Global Healthcare Conference....

BSX : 92.64 (-4.27%)
BAX : 28.14 (-8.49%)
MASI : 151.49 (-7.95%)
CAH : 128.88 (-1.20%)
What To Expect From CooperCompanies’s (COO) Q4 Earnings

What To Expect From CooperCompanies’s (COO) Q4 Earnings

COO : 75.37 (-3.25%)
BSX : 92.64 (-4.27%)
BAX : 28.14 (-8.49%)
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

ABT : 124.50 (-2.00%)
SYK : 348.39 (-4.02%)
BSX : 92.64 (-4.27%)
BAX : 28.14 (-8.49%)
NEOG : 5.63 (+12.15%)
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

ABT : 124.50 (-2.00%)
SYK : 348.39 (-4.02%)
BSX : 92.64 (-4.27%)
BAX : 28.14 (-8.49%)
NEOG : 5.63 (+12.15%)
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

ABT : 124.50 (-2.00%)
SYK : 348.39 (-4.02%)
BSX : 92.64 (-4.27%)
BAX : 28.14 (-8.49%)
NEOG : 5.63 (+12.15%)
Stock market today: A slide for Walmart pulls Wall Street from its record, and Dow drops 450

Wall Street retreated from its record after a sharp slide for Walmart weighed on U.S. stock indexes

MSFT : 381.35 (-2.34%)
COST : 964.31 (-0.09%)
TSLA : 252.40 (-7.27%)
$SPX : 5,268.05 (-3.46%)
SHAK : 82.21 (-6.17%)
BAX : 28.14 (-8.49%)
$DOWI : 39,593.66 (-2.50%)
$IUXX : 18,343.57 (-4.19%)
AMZN : 181.22 (-5.17%)
PLTR : 88.59 (-3.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery,...

See More

Key Turning Points

3rd Resistance Point 32.36
2nd Resistance Point 31.31
1st Resistance Point 29.72
Last Price 28.14
1st Support Level 27.08
2nd Support Level 26.03
3rd Support Level 24.44

See More

52-Week High 42.47
Fibonacci 61.8% 36.28
Fibonacci 50% 34.36
Fibonacci 38.2% 32.45
Last Price 28.14
52-Week Low 26.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar